2018
DOI: 10.2217/nnm-2018-0259
|View full text |Cite
|
Sign up to set email alerts
|

Preparation, structure, Cytotoxicity and Mechanism of Action of ferritin-Pt(II) Terpyridine Compound Nanocomposites

Abstract: Aim: A Pt(II)-terpyridine compound, bearing two piperidine substituents at positions 2 and 2' of the terpyridine ligand (1), is highly cytotoxic and shows a mechanism of action distinct from cisplatin. 1 has been incorporated within the ferritin nanocage (AFt). Materials & methods: Spectroscopic and crystallographic data of the Pt(II)-AFt nanocomposite have been collected and in vitro anticancer activity has been explored using cancer cells. Results: Pt(II)-containing fragments bind His49, His114 and His132. P… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 37 publications
1
7
0
Order By: Relevance
“…Since more than one molecule of AP-1 per AFt chain is present, analysis of the protein structure points out that there are a lot of free AP-1 molecules trapped within the bulk. Similar results were found for other metallodrug-encapsulated Ft systems [40][41][42]. These molecules are responsible for the biological activity of the nanocomposite.…”
Section: Discussionsupporting
confidence: 85%
“…Since more than one molecule of AP-1 per AFt chain is present, analysis of the protein structure points out that there are a lot of free AP-1 molecules trapped within the bulk. Similar results were found for other metallodrug-encapsulated Ft systems [40][41][42]. These molecules are responsible for the biological activity of the nanocomposite.…”
Section: Discussionsupporting
confidence: 85%
“…Although we have not studied the mechanism of release of DiRu‐1 from DiRu‐1‐encapsulated AFt, we expect that the action of DiRu‐1‐encapsulated AFt could be associated with the release of the drug in the acidic endosome compartment, as it is well known that lowering the pH to the highly acidic range leads to the release of the content of the AFt cage . DiRu‐1‐encapsulated AFt induces cancer cell death via ROS production, depolarization of mitochondrial potential, and finally apoptosis (accumulation of nuclear p53‐P‐Ser15).…”
Section: Discussionmentioning
confidence: 99%
“…The reversible process has been widely employed to encapsulate small molecules within its interior . Furthermore, apoferritin has been employed widely to encapsulate small molecules into internal cavity based on the pH-dependent disassembly and reassembly properties. …”
Section: Introductionmentioning
confidence: 99%